Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2010
06/10/2010WO2010065162A1 Composition for the use to treat alzheimer' s disease
06/10/2010WO2010065157A2 Inactivated pepsin fragments for modulating immune system activity against human malignant tumor cells
06/10/2010WO2010065069A2 Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system related disorders
06/10/2010WO2010065061A2 Modular ingestible capsule
06/10/2010WO2010065059A1 Perfluorocarbon gel formulations
06/10/2010WO2010064988A1 Bioadhesive patch
06/10/2010WO2010064882A1 Thick pine needle extract composition for capsulation
06/10/2010WO2010064522A1 Inhalant comprising modified superoxide dismutase
06/10/2010WO2010064441A1 Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof
06/10/2010WO2010064267A1 Platelets lysate and bioadesive compositions thereof for the treatment of mucositis
06/10/2010WO2010064261A1 Synergistic combinations of aztreonam with the carbapenems meropenem and ertapenem
06/10/2010WO2010064251A1 Hydrogel sponges, methods of producing them and uses thereof
06/10/2010WO2010064139A2 Zaleplon gastroretentive drug delivery system
06/10/2010WO2010064126A2 Controlled release dosage forms
06/10/2010WO2010064100A1 Baclofen gastroretentive drug delivery system
06/10/2010WO2010063998A2 Antibiotic nanomaterial
06/10/2010WO2010063997A1 Telmisartan formulations
06/10/2010WO2010063995A2 Telmisartan with diuretic formulations
06/10/2010WO2010063988A1 Germicidal topical compositions
06/10/2010WO2010063937A1 Method for manufacturing capsule series, and related capsule series
06/10/2010WO2010063824A1 Novel composition for treatment of essential thrombocythemia
06/10/2010WO2010063756A1 Formulations for systemic buccal delivery comprising s- adenosylmethionine, their preparation and use
06/10/2010WO2010063667A2 Pharmaceutical composition comprising ezetimibe and simvastatin
06/10/2010WO2010063630A2 Pancreatic tumour treatment
06/10/2010WO2010063493A1 Oral dosage forms of bendamustine
06/10/2010WO2010063476A2 Solid dosage forms of bendamustine
06/10/2010WO2010063387A1 Extrudate having spicular active substances
06/10/2010WO2010063163A1 A patch of antiemetic agent
06/10/2010WO2010063080A1 Amphiphile prodrugs
06/10/2010WO2010045435A3 Salicylic acid composition
06/10/2010WO2010045415A3 Topical nsaid compositions having sensate component
06/10/2010WO2010043772A8 Method of protecting cells
06/10/2010WO2010043446A3 Preparations for the controlled release of active agents
06/10/2010WO2010037878A9 Utilisation of nanoparticles of noble metals as immunomodulators and immunomodulator composition
06/10/2010WO2010037728A3 Formulations comprising ezetimibe
06/10/2010WO2010036938A3 Nanoemulsion therapeutic compositions and methods of using the same
06/10/2010WO2010034497A3 Compacted cinacalcet
06/10/2010WO2010025251A3 Materials and methods for modulating appetite, weight gain and adhd using varenicline
06/10/2010WO2010019643A3 An extracorporeal cell-based therapeutic device and delivery system
06/10/2010WO2010011319A3 Magnetic heating for drug delivery and other applications
06/10/2010WO2010009111A4 A drug depot implantable within a synovial joint
06/10/2010WO2010000348A3 Foaming skincare cream
06/10/2010WO2009121514A3 Self-destructing transdermal therapeutic system having improved functionality and efficacy
06/10/2010WO2009104051A3 Combinational therapeutics for treatment of prostate cancer using epoxy encapsulated magnetic particles and rnai medicine
06/10/2010WO2009014781A3 Metal-containing materials for treatment of bacterial conditions
06/10/2010US20100145018 Lipid-Polymer-Conjugates
06/10/2010US20100144894 Use of dicalcium phosphate anhydride powder
06/10/2010US20100144697 Stabilized pharmaceutical compositions containing a calcium channel blocker
06/10/2010US20100144696 Stabilized pharmaceutical compositions containing a calcium channel blocker
06/10/2010US20100144593 Pharmaceutical Compositions and Methods for Insulin Treatment
06/10/2010US20100143962 Nanoparticulate polycosanol formulations & novel polycosanol combinations
06/10/2010US20100143493 Ophthalmic solutions
06/10/2010US20100143487 Biocompatible protein-based particles and methods thereof
06/10/2010US20100143486 Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same
06/10/2010US20100143485 Oxycontin controlled release formulations and methods of using same
06/10/2010US20100143484 Oral submicron particle delivery system for proteins and process for its production
06/10/2010US20100143483 Pharmaceutical compositions
06/10/2010US20100143482 Method of producing microcapsules
06/10/2010US20100143481 Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
06/10/2010US20100143480 Tricalcium phosphate coarse particle compositions and methods for making the same
06/10/2010US20100143479 Method of making sustained release microparticles
06/10/2010US20100143478 Treatment of inflammation and the complement and kinin cascades in a patient, particularly in chronic ulcerous skin lesions
06/10/2010US20100143477 Methods and Compositions for Stimulating the Proliferation or Differentiation of Stem Cells with Substance Por an Analog Thereof
06/10/2010US20100143476 Composition for stimulating formation of vascular structures
06/10/2010US20100143475 Transdermal therapeutic system with two-phase release profile
06/10/2010US20100143474 B-carboline for the treatment of neurodegenerative diseases
06/10/2010US20100143473 Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions
06/10/2010US20100143472 Osmotic form for controlled release of active principles
06/10/2010US20100143471 Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine
06/10/2010US20100143470 Controlled release pharmaceutical composition containing thiazides and angiotensin-ii-receptor blockers
06/10/2010US20100143469 Pharmaceutical compositions
06/10/2010US20100143468 Tranexamic Acid Formulations
06/10/2010US20100143467 Pharmaceutical tablets with diffractive microstructure and compression tools for producing such tablets
06/10/2010US20100143466 Modified release ibuprofen dosage form
06/10/2010US20100143465 Pharmaceutical composition
06/10/2010US20100143464 Cross-linked alginate-polyalkylene glycol polymer coatings for encapsulation and methods of making the same
06/10/2010US20100143463 Bacterial diversity
06/10/2010US20100143462 New carbamazephine formulations having inproved solubility
06/10/2010US20100143461 Palonosetron formulation
06/10/2010US20100143460 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof
06/10/2010US20100143459 Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
06/10/2010US20100143458 Glutamic acid decarboxylase (gad) based delivery system
06/10/2010US20100143457 Extended soluble PH20 polypeptides and uses thereof
06/10/2010US20100143456 Model membrane systems
06/10/2010US20100143454 Flavivirus NS5A Proteins For the Treatment of HIV
06/10/2010US20100143453 Anti-inflammatory compounds containing compositions for treatment of cancer
06/10/2010US20100143452 Polyphenol containing compositions
06/10/2010US20100143451 Composition for Improving Skin Condition and Appearance
06/10/2010US20100143450 DEVELOPMENT OF ASTHMA THERAPY WITH rAAV-mediated AMCase shRNA
06/10/2010US20100143449 Analgesic composition of topically applied nonsteroidal antiinflammatory drugs and opioids
06/10/2010US20100143448 Multiple nozzle transdermal drug delivery system
06/10/2010US20100143446 Novel skin moisturizing compositions
06/10/2010US20100143445 Dermatological/cosmetic skin depigmenting compositions
06/10/2010US20100143444 Peptides and peptide mimetics to treat pathologies associated with eye disease
06/10/2010US20100143441 Nortriptyline compounds for promoting bone growth
06/10/2010US20100143440 Ul97 inhibitors for treatment of proliferative disorders
06/10/2010US20100143439 Hybrid Biomimetic Particles, Methods of Making Same and Uses Therefor
06/10/2010US20100143437 Implantable analgesic
06/10/2010US20100143436 Self-assembly of protein-based biomaterials with multiple morphologies
06/10/2010US20100143435 Scaffold with increased pore size
1 ... 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 ... 2991